@article{53b514b278524988855e78376c484bf3,
title = "Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative",
keywords = "ENDOMETRIAL STROMAL SARCOMA, SOFT-TISSUE SARCOMA, GROWTH-FACTOR RECEPTOR, AKT-MTOR PATHWAY, MAMMALIAN TARGET, BREAST-CANCER, CYCLIN D1, EXPRESSION, TUMORS, TRIAL",
author = "Tine Cuppens and Daniela Annibali and An Coosemans and Jone Trovik and {ter Haar}, Natalja and Eva Colas and Angel Garcia-Jimenez and {Van de Vijver}, Koen and Kruitwagen, {Roy P. M.} and Mariel Brinkhuis and Michal Zikan and Pavel Dundr and Jutta Huvila and Olli Carpen and Johannes Haybaeck and Farid Moinfar and Salvesen, {Helga B.} and Maciej Stukan and Carole Mestdagh and Zweemer, {Ronald P.} and Massuger, {Leonardus F.} and Mallmann, {Michael R.} and Eva Wardelmann and Miriam Mints and Godelieve Verbist and Debby Thomas and Ellen Gomme and Els Hermans and Philippe Moerman and Tjalling Bosse and Frederic Amant",
year = "2017",
month = mar,
day = "1",
doi = "10.1158/1078-0432.CCR-16-2149",
language = "English",
volume = "23",
pages = "1274--1285",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "5",
}